| Year |
Citation |
Score |
| 2024 |
Unda SR, Pomeranz LE, Marongiu R, Yu X, Kelly L, Hassanzadeh G, Molina H, Vaisey G, Wang P, Dyke JP, Fung EK, Grosenick L, Zirkel R, Antoniazzi AM, Norman S, et al. Bidirectional regulation of motor circuits using magnetogenetic gene therapy. Science Advances. 10: eadp9150. PMID 39383230 DOI: 10.1126/sciadv.adp9150 |
0.74 |
|
| 2023 |
Platholi J, Marongiu R, Park L, Yu F, Sommer G, Weinberger R, Tower W, Milner TA, Glass MJ. Hippocampal glial inflammatory markers are differentially altered in a novel mouse model of perimenopausal cerebral amyloid angiopathy. Frontiers in Aging Neuroscience. 15: 1280218. PMID 38035277 DOI: 10.3389/fnagi.2023.1280218 |
0.602 |
|
| 2023 |
Unda SR, Marongiu R, Pomeranz LE, Dyke JP, Fung EK, Grosenick L, Zirkel R, Antoniazzi AM, Norman S, Liston CM, Schaffer C, Nishimura N, Stanley SA, Friedman JM, Kaplitt MG. Bidirectional Regulation of Motor Circuits Using Magnetogenetic Gene Therapy. Biorxiv : the Preprint Server For Biology. PMID 37503198 DOI: 10.1101/2023.07.13.548699 |
0.744 |
|
| 2022 |
Unda SR, Marciano S, Milner TA, Marongiu R. State-of-the-art review of the clinical research on menopause and hormone replacement therapy association with Parkinson's disease: What meta-analysis studies cannot tell us. Frontiers in Aging Neuroscience. 14: 971007. PMID 36337706 DOI: 10.3389/fnagi.2022.971007 |
0.725 |
|
| 2022 |
Milner TA, Chen RX, Welington D, Rubin BR, Contoreggi NH, Johnson MA, Mazid S, Marques-Lopes J, Marongiu R, Glass MJ. Angiotensin II differentially affects hippocampal glial inflammatory markers in young adult male and female mice. Learning & Memory (Cold Spring Harbor, N.Y.). 29: 265-273. PMID 36206386 DOI: 10.1101/lm.053507.121 |
0.564 |
|
| 2021 |
Unda SR, Antoniazzi AM, Altschul DJ, Marongiu R. Peripheral Leukocytosis Predicts Cognitive Decline but Not Behavioral Disturbances: A Nationwide Study of Alzheimer's and Parkinson's Disease Patients. Dementia and Geriatric Cognitive Disorders. 1-10. PMID 34058741 DOI: 10.1159/000516340 |
0.667 |
|
| 2017 |
Kelm-Nelson CA, Brauer AFL, Barth KJ, Lake JM, Sinnen MLK, Stehula FJ, Muslu C, Marongiu R, Kaplitt MG, Ciucci MR. Characterization of early-onset motor deficits in the Pink1 -/- mouse model of Parkinson disease. Brain Research. PMID 29229503 DOI: 10.1016/J.Brainres.2017.12.002 |
0.709 |
|
| 2016 |
Marongiu R, Arango-Lievano M, Francardo V, Morgenstern P, Zhang X, Cenci MA, Svenningsson P, Greengard P, Kaplitt MG. Gene therapy blockade of dorsal striatal p11 improves motor function and dyskinesia in parkinsonian mice. Proceedings of the National Academy of Sciences of the United States of America. PMID 26787858 DOI: 10.1073/Pnas.1524387113 |
0.737 |
|
| 2016 |
Schintu N, Zhang X, Alvarsson A, Marongiu R, Kaplitt MG, Greengard P, Svenningsson P. p11 modulates L-DOPA therapeutic effects and dyskinesia via distinct cell types in experimental Parkinsonism. Proceedings of the National Academy of Sciences of the United States of America. PMID 26787846 DOI: 10.1073/Pnas.1524303113 |
0.735 |
|
| 2015 |
Gürsel DB, Banu MA, Berry N, Marongiu R, Burkhardt JK, Kobylarz K, Kaplitt MG, Rafii S, Boockvar JA. Tight regulation between cell survival and programmed cell death in GBM stem-like cells by EGFR/GSK3b/PP2A signaling. Journal of Neuro-Oncology. 121: 19-29. PMID 25344882 DOI: 10.1007/S11060-014-1602-3 |
0.644 |
|
| 2014 |
Arango-Lievano M, Schwarz JT, Vernov M, Wilkinson MB, Bradbury K, Feliz A, Marongiu R, Gelfand Y, Warner-Schmidt J, Nestler EJ, Greengard P, Russo SJ, Kaplitt MG. Cell-type specific expression of p11 controls cocaine reward. Biological Psychiatry. 76: 794-801. PMID 24725970 DOI: 10.1016/J.Biopsych.2014.02.012 |
0.69 |
|
| 2012 |
Lenzi P, Marongiu R, Falleni A, Gelmetti V, Busceti CL, Michiorri S, Valente EM, Fornai F. A subcellular analysis of genetic modulation of PINK1 on mitochondrial alterations, autophagy and cell death. Archives Italiennes De Biologie. 150: 194-217. PMID 23165879 DOI: 10.4449/Aib.V150I2/3.1417 |
0.516 |
|
| 2012 |
Lenzi P, Falleni A, Marongiu R, Valente EM, Ricciardi MP, Ruggieri S, Frati L, Paparelli A. Genetic modulation of PINK1 differentially affects mitophagy compared with autophagy disclosing common mechanisms of genetic and environmental parkinsonism Italian Journal of Anatomy and Embryology. 117: 97-97. DOI: 10.13128/Ijae-12029 |
0.538 |
|
| 2011 |
Morgenstern PF, Marongiu R, Musatov SA, Kaplitt MG. Adeno-associated viral gene delivery in neurodegenerative disease. Methods in Molecular Biology (Clifton, N.J.). 793: 443-55. PMID 21913118 DOI: 10.1007/978-1-61779-328-8_29 |
0.678 |
|
| 2010 |
Michiorri S, Gelmetti V, Giarda E, Lombardi F, Romano F, Marongiu R, Nerini-Molteni S, Sale P, Vago R, Arena G, Torosantucci L, Cassina L, Russo MA, Dallapiccola B, Valente EM, et al. The Parkinson-associated protein PINK1 interacts with Beclin1 and promotes autophagy. Cell Death and Differentiation. 17: 962-74. PMID 20057503 DOI: 10.1038/Cdd.2009.200 |
0.556 |
|
| 2009 |
Marongiu R, Spencer B, Crews L, Adame A, Patrick C, Trejo M, Dallapiccola B, Valente EM, Masliah E. Mutant Pink1 induces mitochondrial dysfunction in a neuronal cell model of Parkinson's disease by disturbing calcium flux. Journal of Neurochemistry. 108: 1561-74. PMID 19166511 DOI: 10.1111/J.1471-4159.2009.05932.X |
0.697 |
|
| 2008 |
Marongiu R, Ferraris A, Ialongo T, Michiorri S, Soleti F, Ferrari F, Elia AE, Ghezzi D, Albanese A, Altavista MC, Antonini A, Barone P, Brusa L, Cortelli P, Martinelli P, et al. PINK1 heterozygous rare variants: prevalence, significance and phenotypic spectrum. Human Mutation. 29: 565. PMID 18330912 DOI: 10.1002/Humu.20719 |
0.56 |
|
| 2007 |
Marongiu R, Brancati F, Antonini A, Ialongo T, Ceccarini C, Scarciolla O, Capalbo A, Benti R, Pezzoli G, Dallapiccola B, Goldwurm S, Valente EM. Whole gene deletion and splicing mutations expand the PINK1 genotypic spectrum. Human Mutation. 28: 98. PMID 17154281 DOI: 10.1002/Humu.9472 |
0.519 |
|
| 2006 |
Criscuolo C, Volpe G, De Rosa A, Varrone A, Marongiu R, Mancini P, Salvatore E, Dallapiccola B, Filla A, Valente EM, De Michele G. PINK1 homozygous W437X mutation in a patient with apparent dominant transmission of parkinsonism. Movement Disorders : Official Journal of the Movement Disorder Society. 21: 1265-7. PMID 16700027 DOI: 10.1002/Mds.20933 |
0.54 |
|
| 2006 |
Marongiu R, Ghezzi D, Ialongo T, Soleti F, Elia A, Cavone S, Albanese A, Altavista MC, Barone P, Brusa L, Cortelli P, Petrozzi L, Scaglione C, Stanzione P, Tinazzi M, et al. Frequency and phenotypes of LRRK2 G2019S mutation in Italian patients with Parkinson's disease. Movement Disorders : Official Journal of the Movement Disorder Society. 21: 1232-5. PMID 16622859 DOI: 10.1002/Mds.20890 |
0.523 |
|
| 2004 |
Valente EM, Salvi S, Ialongo T, Marongiu R, Elia AE, Caputo V, Romito L, Albanese A, Dallapiccola B, Bentivoglio AR. PINK1 mutations are associated with sporadic early-onset parkinsonism. Annals of Neurology. 56: 336-41. PMID 15349860 DOI: 10.1002/Ana.20256 |
0.511 |
|
| Show low-probability matches. |